Repligen

Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs. The company is based in Waltham, Massachusetts, and incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN

IMAPAC is the go-to holistic producer of live events, biopharma data and digital marketing solutions for the global biopharmaceutical industry.

© 2023 Imapac. All rights reserved. Trade marks are owned by or licensed to imapac.

ABOUT IMAPAC

About Us

Newsletter

Newsroom

OUR SERVICES

Biopharma Conferences

Market Intelligence

Digital Advertising

GET IN TOUCH

Contact Us

Become A Client

Careers

FOLLOW US ON